15 years of PTP research 

•Michel L. Tremblay Ph.D., F.R.S.C.

  • Full Professor, Jeanne and Jean-Louis Levesque Chair in Cancer Research James McGill Chair, McGill University
  • Founder and Former Director of the Goodman Cancer Research Centre
  • Co-Founder of Mispro Biotech Services


•Brian Kennedy, Ph. D.

  • Former Senior Director of Biology and Site Lead for Cardiovascular and Metabolic Diseases at Merck Frosst
  • Discovered and led the PTP-1B program
  • Co-Founder of Kaneq Pharma and Kaneq Bioscience


•Cameron Black, Ph. D.

  • Former Director of Chemistry and Scientific Operations Lead at Merck Frosst
  • Led Previcox and Odanacatib discovery and development teams
  • Co-Founder of Kaneq Pharma and Kaneq Bioscience


•Daniel Bouthillier, Ph.D., MBA, CSPQ

  • Former Executive Director for Global Facilities Management and Research Administration and Planning for various Merck sites worldwide
  • Co-Founder of Kaneq Pharma and Kaneq Bioscience